Kris Vaddi, PhD

Kris Vaddi, PhD

Kris Vaddi, Ph.D. is a drug discovery scientist and the founder of cancer focused startup companies Orsenix and Prelude Therapeutics, and a not-for-profit venture Sidus Healthcare. Prior to his new ventures, Kris had a 14-year career at Incyte starting as a founding...
Peggy Scherle, PhD

Peggy Scherle, PhD

Dr. Scherle is Chief Scientific Officer at Prelude. Prior to joining Prelude, Dr. Scherle was Group Vice President, Discovery Biology and Preclinical Pharmacology at Incyte Corporation and oversaw the target validation and drug discovery efforts for both the small and...
Aimee Crombie, PhD

Aimee Crombie, PhD

Aimee Crombie, Ph.D. is Vice President of R&D Operations at Prelude Therapeutics. Prior to joining Prelude, she was Vice President of Research at Trevena, Inc. where she oversaw drug discovery activities supporting target and hit identification, chemical lead...